Nodular regenerative hyperplasia in CVID patients: could low-dose oral glucocorticoids be part of the solution?

Eur Ann Allergy Clin Immunol. 2022 Mar 18. doi: 10.23822/EurAnnACI.1764-1489.251. Online ahead of print.NO ABSTRACTPMID:35301845 | DOI:10.23822/EurAnnACI.1764-1489.251

Source: European Annals of Allergy and Clinical Immunology - March 18, 2022 Category: Allergy & Immunology Authors: R Sousa eSilva S Pereira da Silva R Lu ís C Baldaia S Lopes da Silva Source Type: research